MSD Animal Health has presented new clinical trial data showing its oral drug NUMELVI® (atinvicitinib) significantly reduces itching and skin inflammation in dogs with atopic and allergic dermatitis.

OZMOSI and Planview have partnered to integrate structured clinical datasets with AI-driven portfolio planning, aiming to connect real-world scientific data with internal R&D strategies. The move ...

Last November, the UK government announced a bold plan to phase out animal testing in some areas of research. Animal tests for skin irritation are scheduled for elimination this year, and some studies ...

Scientists often encounter translational barriers when moving drug candidates from the laboratory to the clinic.

The U.S. Food and Drug Administration recently approved the first-ever clinical trial of the transplantation of a nonhuman animal organ—a genetically modified pig kidney—into living human recipients.